Skip to content
Screener

Harrow HROW Total Liabilities & Equity

Total Liabilities & Equity at other companies

AbbVie logo
AbbVieABBV
$136.46B+0.2%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$97.71M+16.3%
Bausch + Lomb logo
Bausch + LombBLCO
$13.86B+0.2%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$732.53M+80.5%
Opko Health logo
Opko HealthOPK
$1.83B-7.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$24.5B-7.3%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.7B+5.6%
P/S5.5×+0.2×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Harrow’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-022254
Line itemMarch 31, 2026December 31, 2025
STOCKHOLDERS’ EQUITY
Common stock, $0.001 par value, 50,000,000 shares authorized, 37,269,400 and 37,229,159 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively37,00037,000
Additional paid-in capital212,795,000208,933,000
Accumulated deficit(184,126,000)(156,524,000)
TOTAL HARROW, INC. STOCKHOLDERS’ EQUITY28,706,00052,446,000
Noncontrolling interests(355,000)(355,000)
TOTAL STOCKHOLDERS’ EQUITY28,351,00052,091,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$419,543,000$399,482,000

Item 1. Financial Statements (unaudited) Item

FAQ

What is Harrow's total liabilities & equity?
Harrow (HROW) reported total liabilities & equity of $419.54M in Q1 2026.
How has Harrow's total liabilities & equity changed year-over-year?
Harrow's total liabilities & equity increased by 15.2% year-over-year, from $364.16M to $419.54M.
What is the long-term trend for Harrow's total liabilities & equity?
Over 5 years (2020 to 2025), Harrow's total liabilities & equity has grown at a 47.4% compound annual growth rate (CAGR), from $57.47M to $399.48M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Harrow's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude